Skip to main content
. 2020 Jun 23;14:1037–1047. doi: 10.2147/PPA.S232578

Table 4.

Factors Influencing the Patients’ Satisfaction with bDMARDs, Detected Using Multivariable Linear Regression Analysis

Factors β Se Adjusted β P
Age 0.037 0.099 0.021 0.712
Profession
 Office workers Reference
 Service staff 1.507 4.457 0.021 0.736
 Agricultural, forestry, animal husbandry, fisheries, and auxiliary personnel −0.501 4.843 −0.007 0.918
 Manufacturing and related personnel −2.976 6.668 −0.026 0.656
 Soldier and others 2.21 3.44 0.046 0.521
Education Level
 Junior high school and below Reference
 Senior high school −4.69 3.352 −0.092 0.163
 College or above −8.397 3.742 −0.175 0.026
Duration of Rheumatoid Arthritis (Years)
 <2 Reference
 2–5 −10.675 3.567 −0.207 0.003
 6–10 −7.456 3.772 −0.135 0.049
 >10 −15.578 3.753 −0.29 <0.001
Severity of the Disease Assessed by the Patient
 Severe Reference
 Moderate 3.15 3.466 0.068 0.364
 Mild 2.369 3.957 0.045 0.550
 Extremely mild 16.634 7.736 0.122 0.032
Communication with Physicians
 Full communication Reference
 Good communication, but a little hasty −7.79 3.036 −0.144 0.011
 Average communication level and can get the information −8.008 4.534 −0.095 0.078
 Less communication with physicians −5.296 5.302 −0.054 0.319
 Basically no communication −7.553 13.151 −0.031 0.566
Cost of Treatment for Rheumatoid Arthritis, Proportion of Household Income (%)
 <10 Reference
 10–30 −5.222 4.259 −0.107 0.221
 31–50 −9.376 4.622 −0.167 0.043
 >50 −8.731 4.510 −0.174 0.054

Abbreviations: RA, rheumatoid arthritis; bDMARDs, biological disease-modifying antirheumatic drugs; TSQM-II, Treatment Satisfaction Questionnaire for Medication, version II; CREDIT, Chinese Registry of Rheumatoid Arthritis; EULAR, European League Against Rheumatism; ACR, American College of Rheumatology; DAS28, Disease Activity Score 28; SD, standard deviation; csDMARDS, conventional synthetic disease-modifying antirheumatic drugs; DAS28-ESR, disease activity score 28-erythrocyte sedimentation rate; DAS28-CRP, disease activity score 28-C-reactive protein; PtGA, patient global assessment of disease activity; bDMARDs, biological disease-modifying antirheumatic drugs.